The link between kidney disease and cancer: complications and treatment

J Malyszko, P Tesarova, G Capasso, A Capasso - The Lancet, 2020 - thelancet.com
Acute and chronic kidney disease encompasses a complex set of diseases that can both
lead to, and result from, cancer. In particular, kidney disease can arise from the use of …

[HTML][HTML] New approaches in primary central nervous system lymphoma

E Fraser, K Gruenberg, JL Rubenstein - Chinese clinical oncology, 2015 - ncbi.nlm.nih.gov
Primary central nervous system lymphoma (PCNSL) has long been associated with an
inferior prognosis compared to other aggressive non-Hodgkin's lymphomas (NHLs) …

What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?

BS Chan, AH Dawson, NA Buckley - Clinical Toxicology, 2017 - Taylor & Francis
Context: Methotrexate (MTX) is an anti-folate drug that has been utilized in both malignant
and chronic inflammatory conditions. Doctors are often concerned with a potential adverse …

Management of patients with acute methotrexate nephrotoxicity with high‐dose leucovorin

CD Flombaum, D Liu, SQ Yan, A Chan… - … : The Journal of …, 2018 - Wiley Online Library
Background Acute kidney injury complicating high‐dose methotrexate (HDMTX) therapy
increases the risk for severe mucositis, myelosuppression, and death. It is unclear whether …

Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study

B Demiralp, L Koenig, J Kala, C Feng… - ClinicoEconomics …, 2019 - Taylor & Francis
Purpose Glucarpidase (Voraxaze) is used to treat methotrexate (Mtx) toxicity in patients with
delayed Mtx clearance due to impaired renal function. We examine hospital length of stay …

Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: A cohort study of 468 patients

C Medrano, L Oberic, F Puisset, C Recher… - Leukemia & …, 2021 - Taylor & Francis
The aims of this study were to characterize the incidence and outcomes of severe toxicities
following the administration of high-dose methotrexate (HD-MTX;≥ 1 g/m2). Among the 468 …

High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What's best?

A Kitchlu, AC Shirali - Journal of Onco-Nephrology, 2019 - journals.sagepub.com
Kidney-related adverse drug effects from chemotherapeutic agents can cause acute kidney
injury that may influence cancer treatment and patient outcomes. Many current …

Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase

BS Chan, AA Bosco, NA Buckley - British Journal of Clinical …, 2024 - Wiley Online Library
Methotrexate (MTX) toxicity varies depending on factors such as dosing frequency (acute or
repeated), dosage (low or high) and the administration route (oral, parenteral or intrathecal) …

Therapeutic drug monitoring using mass spectrometry

PJ Jannetto - Mass spectrometry for the clinical laboratory, 2017 - Elsevier
Therapeutic drug monitoring (TDM), the measurement of medications in whole blood, serum,
or plasma, plays a vital part in the management of patient's prescribed drugs with narrow …

Methotrexate

DR Mager - Home healthcare now, 2015 - journals.lww.com
Methotrexate : Home Healthcare Now Methotrexate : Home Healthcare Now Log in or Register
Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal Logo …